Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer
出版年份 2023 全文链接
标题
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer
作者
关键词
-
出版物
CANCER CELL
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-11-02
DOI
10.1016/j.ccell.2023.10.006
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
- (2022) Thomas Powles et al. NATURE MEDICINE
- Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function
- (2022) Joshua R. Veatch et al. CANCER CELL
- Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
- (2021) Sujun Chen et al. NATURE CELL BIOLOGY
- Transcriptional mediators of treatment resistance in lethal prostate cancer
- (2021) Meng Xiao He et al. NATURE MEDICINE
- Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
- (2021) Lauren Brady et al. Nature Communications
- Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor Model
- (2021) Casey R Ager et al. Cancer Immunology Research
- How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer
- (2021) Jacob Stultz et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047 (CA224-047).
- (2021) Evan J. Lipson et al. JOURNAL OF CLINICAL ONCOLOGY
- Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment
- (2021) Youmna Kfoury et al. CANCER CELL
- Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐C
- (2021) Elin Thysell et al. Molecular Oncology
- Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy
- (2020) Jessica E. Hawley et al. PROSTATE
- T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer
- (2020) Aleksandar Z. Obradovic et al. CLINICAL CANCER RESEARCH
- Regenerative potential of prostate luminal cells revealed by single-cell analysis
- (2020) Wouter R. Karthaus et al. SCIENCE
- First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors
- (2020) Ravit Geva et al. CANCER
- Genomic and phenotypic heterogeneity in prostate cancer
- (2020) Michael C. Haffner et al. Nature Reviews Urology
- Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
- (2020) Baijun Dong et al. Communications Biology
- Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
- (2019) Dvir Aran et al. NATURE IMMUNOLOGY
- Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
- (2019) Elisabeth Perez-Ruiz et al. NATURE
- Rational design of anti-GITR-based combination immunotherapy
- (2019) Roberta Zappasodi et al. NATURE MEDICINE
- GITR agonism — combination is key
- (2019) David Killock Nature Reviews Clinical Oncology
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Characterization and comparison of GITR expression in solid tumors
- (2019) Luis Vence et al. CLINICAL CANCER RESEARCH
- The TNF Paradox in Cancer Progression and Immunotherapy
- (2019) Anne Montfort et al. Frontiers in Immunology
- Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
- (2019) Mark P. Labrecque et al. JOURNAL OF CLINICAL INVESTIGATION
- Genomic and clinical characterization of pulmonary‐only metastatic prostate cancer: A unique molecular subtype
- (2019) Eugene Shenderov et al. PROSTATE
- Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor–Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors
- (2019) Kimberley M. Heinhuis et al. JAMA Oncology
- Structure and regulation of human epithelial cell transforming 2 protein
- (2019) Mengran Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer
- (2018) Michael C. Haffner et al. AMERICAN JOURNAL OF PATHOLOGY
- Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation
- (2018) Aerken Maolake et al. CANCER SCIENCE
- Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
- (2018) David A. Quigley et al. CELL
- Inhibitors of the PD-1 Pathway in Tumor Therapy
- (2018) Martin W. LaFleur et al. JOURNAL OF IMMUNOLOGY
- A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
- (2018) Mariano J. Alvarez et al. NATURE GENETICS
- Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm
- (2018) Hongxu Ding et al. Nature Communications
- Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses
- (2018) Amanda J. Oliver et al. Frontiers in Immunology
- Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors
- (2018) Ben Tran et al. Journal for ImmunoTherapy of Cancer
- Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model
- (2017) Ying-Chun Shen et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer
- (2017) Yixiang Zhang et al. Oncotarget
- ARACNe-AP: gene network reverse engineering through adaptive partitioning inference of mutual information
- (2016) Alexander Lachmann et al. BIOINFORMATICS
- Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers
- (2016) Campbell D. Lawson et al. CANCER RESEARCH
- Functional characterization of somatic mutations in cancer using network-based inference of protein activity
- (2016) Mariano J Alvarez et al. NATURE GENETICS
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse
- (2016) Yang Pu et al. Science Translational Medicine
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation
- (2014) Haydn T. Kissick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival
- (2014) Jaya Sharma et al. PROSTATE
- Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
- (2013) Edward Y Chen et al. BMC BIOINFORMATICS
- BLUEPRINT: mapping human blood cell epigenomes
- (2013) J. H. A. Martens et al. HAEMATOLOGICA
- Androgen Regulation of the TMPRSS2 Gene and the Effect of a SNP in an Androgen Response Element
- (2013) Liesbeth Clinckemalie et al. MOLECULAR ENDOCRINOLOGY
- Increased CD8+ T-cell Function following Castration and Immunization Is Countered by Parallel Expansion of Regulatory T Cells
- (2012) S. Tang et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients
- (2010) Carlo Sorrentino et al. CLINICAL CANCER RESEARCH
- Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses
- (2010) Matthew D. Morse et al. HUMAN IMMUNOLOGY
- Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancer
- (2009) Sowmyalakshmi Srinivasan et al. APOPTOSIS
- CCL2 and Interleukin-6 Promote Survival of Human CD11b+Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization
- (2009) Hernan Roca et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients
- (2009) Philippe O. Gannon et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
- (2009) J. F. Grosso et al. JOURNAL OF IMMUNOLOGY
- ETS gene fusions in prostate cancer
- (2009) Jeremy P. Clark et al. Nature Reviews Urology
- Human prostate-infiltrating CD8+T lymphocytes are oligoclonal and PD-1+
- (2009) Karen S. Sfanos et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now